OncoZenge AB (publ) (STO:ONCOZ)
Sweden
· Delayed Price · Currency is SEK 5.36
+0.33 (6.56%)
May 30, 2025, 5:13 PM CET
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 58.92 million as of May 30, 2025. Its market cap has increased by 29.97% in one year.
Market Cap
58.92M
Enterprise Value
57.62M
Revenue
2.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.36
Market Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has decreased from 89.02M to 58.92M, a decrease of -33.82%. That is a compound annual growth rate of -9.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2025 | 58.92M | 34.13% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 100.84B |
| Sectra AB | 60.50B |
| Getinge AB | 50.95B |
| Asker Healthcare Group AB | 38.30B |
| Medicover AB | 35.86B |
| Camurus AB | 29.99B |
| AddLife AB | 22.25B |
| Vimian Group AB | 21.87B |